SCHEMBL5033376

SCHEMBL5033376

O=C(NCc1ccccc1)NC1=COCO1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.54
CFD P00746 1/20 0.49
KDM4E B2RXH2 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
EPHX1 P07099 2/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MAPT P10636 1/20 0.46
TP53 P04637 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
MAOB P27338 1/20 0.46
HTT P42858 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PTPN1 P18031 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL333955 0.76 HSD17B10 (0.39) KDM4ERAB9AMAPTTP53LMNA
SCHEMBL5812651 0.76 RAB9A (0.56) SMN1; SMN2NPC1RAB9ATP53HPGD
SCHEMBL5033380 0.73 CFD (0.49) GSK3BCFDKDM4ESMN1; SMN2EPHX1
SCHEMBL714625 0.73 EPHX1 (0.77) GSK3BCFDKDM4ESMN1; SMN2EPHX1
SCHEMBL2831462 0.72 NPC1 (0.77) CFDKDM4ESMN1; SMN2EPHX1NPC1
SCHEMBL1395125 0.71 GSK3B (0.49) GSK3BCFDKDM4ESMN1; SMN2EPHX1
SCHEMBL1131124 0.71 RIPK1 (0.56) GSK3BSMN1; SMN2RAB9ALMNA
SCHEMBL20804368 0.71 NPC1 (0.65) GSK3BCFDKDM4ESMN1; SMN2NPC1
SCHEMBL4307478 0.70 GSK3B (1.00) GSK3BKDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL7519969 0.70 GSK3B (0.50) GSK3BCFDKDM4ESMN1; SMN2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919465-A2 GSK-3 INHIBITORS Neuropharma S.A. (ES) 2008-05-14 EP disclosed
WO-2007017145-A2 GSK-3 INHIBITORS NEUROPHARMA, S.A. (ES) 2007-02-15 WO disclosed